Etiqueta: stem cell research
-
Cleveland Clinic receives $2.75M grant to study stem cell use in treating MS
The Cleveland Clinic has received a $2.75 million federal grant from the Department of Defense. The study will investigate patients with relapse-remitting MS that are still able to walk but have moderate to severe disability.
-
Researchers Launch Phase II Trial of Stem Cells and Acute Heart Attack
Doctors at the University of Texas Medical School at Houston have announced initiation of an efficacy-finding study in the area of heart failure using a "universal donor" stem cell product called "Prochymal".
-
Stem cells from umbilical cord used for cerebral palsy
In a recent news announcement, a case of a child in Singapore with cerebral palsy that was treated with their own cord blood stem cells was discussed.
-
Adipose Tissue-Derived Stem Cells Inhibit Neointimal Formation in a Paracrine Fashion in Rat Femoral Artery
In the study, fat mesenchymal stem cells were isolated from rats and tested for ability to promote healing of the endothelium, which is the lining of the blood vessels.
-
Stem Cells May Improve Heart Bypass Results
The study demonstrated efficacy in the treated patients based on increase cardiac muscle contraction ability as compared to patients that had bypass surgery but did not receive stem cells.
-
Use of Frozen Stem Cells Successful in Heart Failure
In a recent paper the use of mesenchymal stem cells was evaluated after the cells have been stored frozen.
-
Cord Blood Cells Make New Blood Vessels
A paper published today from the Mary Laughlin’s group describes the use of cord blood cells in creation of new blood vessels.
-
NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12
Today NOXXON announced that is has successfully administered its NOX-A12 aptamer-based mobilizer to healthy volunteers as part of a Phase I clinical trial.
-
Geron Could Resume Stem Cell Trial
Geron stated that subsequent to their recent discussions with the FDA, they believe they will have sufficient new animal data to allow for continuation of the trial sometime in thei third quarter of 2010.
-
Stem Cell Therapeutics Corp. Announces Private Placement
Stem Cell Therapeutics is a biotechnology company from Calgary Canada that is developing a novel type of stem cell therapy: instead of administering stem cells, they give drugs that activate the patient’s own stem cells.